EP3038652
COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.8.2014EP published:
21.3.2018EP application number:
14766301.7
EPO information:
European Patent Register
Max expiry date:
27.8.2034
Title:
COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
Timeline
Today
28.8.2014EP application
21.3.2018EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
HARRIS, Jennifer LeslieAddress:
San Diego, California, US
Name:
LI, NanxinAddress:
San Diego, California, US
Name:
SMITH, Timothy R.Address:
San Diego, California, US
Priority
Number:
201361871275 PDate:
28.8.2013Country:
US
Classification
Categories:
A61K 31/506, A61K 31/519, A61K 45/06, A61P 35/00